From Rs 2.5 Crore pa to Rs 2.5 lakh per annum: Soon, make in India drugs for rare diseases
The Centre has come up with a game-changer special initiative by manufacturing four types of homegrown 'Made in India' drugs for rare diseases for the first time.The Central Government has prioritised 13 rare diseases and sickle cell disease. The most awaited initiative was taken in July 2022 after discussions held with the academia, pharma industries, organisations and CDSCO department...
The Centre has come up with a game-changer special initiative by manufacturing four types of homegrown 'Made in India' drugs for rare diseases for the first time.
The Central Government has prioritised 13 rare diseases and sickle cell disease. The most awaited initiative was taken in July 2022 after discussions held with the academia, pharma industries, organisations and CDSCO department of pharmaceuticals.
For more details, check out the link given below:
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd